Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis

被引:20
|
作者
Srivastava, Shivani [2 ]
Macaubas, Claudia
Deshpande, Chetan
Alexander, Heather C. [3 ]
Chang, Sheng-Yung [3 ]
Sun, Yue
Park, Jane L. [4 ]
Lee, Tzielan [4 ]
Begovich, Ann [3 ]
Mellins, Elizabeth D. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Program Immunol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Biol, Stanford, CA 94305 USA
[3] Celera, Alameda, CA USA
[4] Stanford Univ, Dept Pediat, Div Pediat Rheumatol, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
Systemic juvenile arthritis; Monocytes; Apoptosis; MIGRATION INHIBITORY FACTOR; MACROPHAGE ACTIVATION SYNDROME; TUMOR-NECROSIS-FACTOR; CELL-DEATH APOPTOSIS; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; FAS LIGAND; GENE-EXPRESSION; ALVEOLAR MACROPHAGES; CASPASE-8; ACTIVATION;
D O I
10.1016/j.clim.2010.04.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated whether circulating monocytes from patients with systemic juvenile idiopathic arthritis (SJIA) are resistant to apoptosis and which apoptotic pathway(s) may mediate this resistance. A microarray analysis of peripheral blood mononuclear cells (PBMC) of SJIA samples and RT-PCR analysis of isolated monocytes showed that monocytes from active SJIA patients express transcripts that imply resistance to apoptosis. SJIA monocytes incubated in low serum show reduced annexin binding and diminished FasL up-regulation compared to controls. SJIA monocytes are less susceptible to anti-Fas-induced apoptosis and, upon activation of the mitochondrial pathway with staurosporine, show diminished Bid cleavage and Bcl-w down-regulation compared to controls. Exposure to SJIA plasma reduces responses to apoptotic triggers in normal monocytes. Thus, SJIA monocytes are resistant to apoptosis due to alterations in both the extrinsic and intrinsic apoptosis pathways, and circulating factors associated with active SJIA may confer this phenotype. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:257 / 268
页数:12
相关论文
共 50 条
  • [41] Glucocorticoids in the Management of Systemic Juvenile Idiopathic Arthritis
    Gaia Vannucci
    Luca Cantarini
    Teresa Giani
    Edoardo Marrani
    Davide Moretti
    Ilaria Pagnini
    Gabriele Simonini
    Rolando Cimaz
    Pediatric Drugs, 2013, 15 : 343 - 349
  • [42] Canakinumab (Ilaris) for Systemic Juvenile Idiopathic Arthritis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1423): : 65 - 66
  • [43] JAK inhibitors in systemic juvenile idiopathic arthritis
    He, Tingyan
    Xia, Yu
    Luo, Ying
    Yang, Jun
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [44] Tapering canakinumab in systemic juvenile idiopathic arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (10): : E593 - E593
  • [45] Tocilizumab for Systemic Juvenile Idiopathic Arthritis Reply
    De Benedetti, Fabrizio
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1256 - 1257
  • [46] Systemic Juvenile Idiopathic Arthritis: The Challenges and Opportunities
    Raj, Spoorthy
    Balan, Suma
    INDIAN JOURNAL OF RHEUMATOLOGY, 2024, 19 (04) : 303 - 315
  • [47] Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management
    Kumar, Sathish
    INDIAN JOURNAL OF PEDIATRICS, 2016, 83 (04): : 322 - 327
  • [48] Diagnosis and Treatment of Systemic Juvenile Idiopathic Arthritis
    Shenoi, Susan
    Wallace, Carol A.
    JOURNAL OF PEDIATRICS, 2016, 177 : 19 - 26
  • [49] NLRP3 inflammasome expression in peripheral blood monocytes of patients with systemic juvenile idiopathic arthritis
    Li, Y.
    Lu, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 213 - 213
  • [50] Differential Expression of microRNA in Monocytes from Children with Systemic Juvenile Idiopathic Arthritis: Implications for Polarized Phenotype
    Schulert, Grant
    Fall, Ndate
    Shen, Nan
    Grom, Alexei
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S132 - S133